Apple [AAPL] vs Zepp Health [ZEPP] Detailed Stock Comparison

Apple Inc.

NASDAQ
Loading...

Zepp Health Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Apple Inc. wins in 13 metrics, Zepp Health Corporation wins in 5 metrics, with 0 ties. Apple Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Apple Inc. Zepp Health Corporation Better
P/E Ratio (TTM) 34.35 -6.56 Apple Inc.
Price-to-Book Ratio 45.19 1.20 Zepp Health Corporation
Debt-to-Equity Ratio 102.63 54.21 Zepp Health Corporation
PEG Ratio 1.88 0.09 Zepp Health Corporation
EV/EBITDA 26.18 -175.77 Apple Inc.
Profit Margin (TTM) 27.04% -15.48% Apple Inc.
Operating Margin (TTM) 35.37% -4.55% Apple Inc.
EBITDA Margin (TTM) 35.37% N/A N/A
Return on Equity 152.02% -17.15% Apple Inc.
Return on Assets (TTM) 24.38% -3.34% Apple Inc.
Free Cash Flow (TTM) $98.77B $-25.88M Apple Inc.
Dividend Yield 0.48% N/A N/A
1-Year Return 48.20% 103.03% Zepp Health Corporation
Price-to-Sales Ratio (TTM) 9.14 0.91 Zepp Health Corporation
Enterprise Value $4,003.07B $4.26B Apple Inc.
EV/Revenue Ratio 9.19 16.44 Apple Inc.
Gross Profit Margin (TTM) 48.16% N/A N/A
Revenue per Share (TTM) $29 $16 Apple Inc.
Earnings per Share (Diluted) $7.89 $-2.56 Apple Inc.
Beta (Stock Volatility) 1.11 1.77 Apple Inc.
Short % of Float 0.92% 7.68% Apple Inc.

Apple Inc. vs Zepp Health Corporation Stock Performance Analysis

Loading Price Chart...

AAPL
ZEPP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Apple Inc.0.14%5.84%13.40%23.50%35.28%23.15%
Zepp Health Corporation7.46%-18.45%-50.83%-68.93%-82.20%-82.02%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Apple Inc.48.20%57.44%123.16%1,121.70%2,444.84%14,032.52%
Zepp Health Corporation103.03%0.21%-89.23%-89.70%-89.70%-89.70%

Performance & Financial Health Analysis: Apple Inc. vs Zepp Health Corporation

MetricAAPLZEPP
Market Information
Market Cap i$3.98T$245.12M
Market Cap CategoryMega capMicro cap
10 Day Avg. Volume i44,085,15055,852
90 Day Avg. Volume i41,911,970108,171
Last Close$333.74$5.04
52 Week Range$201.50 - $334.98$2.25 - $61.85
% from 52W High-0.37%-91.85%
All-Time High$334.98 (Jul 17, 2026)$81.00 (Feb 15, 2021)
% from All-Time High-0.37%-93.78%
Growth Metrics
Quarterly Revenue Growth0.16%0.43%
Quarterly Earnings Growth0.16%N/A
Financial Health
Profit Margin (TTM) i0.27%-0.15%
Operating Margin (TTM) i0.35%-0.05%
Return on Equity (TTM) i1.52%-0.17%
Debt to Equity (MRQ) i102.6354.21
Cash & Liquidity
Book Value per Share (MRQ)$6.00$13.51
Cash per Share (MRQ)$4.56$0.23
Operating Cash Flow (TTM) i$135.47B$-25,970,000
Levered Free Cash Flow (TTM) i$106.31B$-116,647,485
Dividends
Last 12-Month Dividend Yield i0.48%N/A
Last 12-Month Dividend i$1.29$0.00

Valuation & Enterprise Metrics Analysis: Apple Inc. vs Zepp Health Corporation

MetricAAPL (Apr 26, 2026)ZEPP (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i34.35-6.56
Forward P/E i28.92231.14
PEG Ratio i1.880.09
Price to Sales (TTM) i9.140.91
Price to Book (MRQ) i45.191.20
Market Capitalization
Market Capitalization i$3.98T$245.12M
Enterprise Value i$4.00T$4.26B
Enterprise Value Metrics
Enterprise to Revenue i9.1916.44
Enterprise to EBITDA i26.18-175.77
Risk & Other Metrics
Beta i1.111.77
Book Value per Share (MRQ) i$6.00$13.51

Financial Statements Comparison: Apple Inc. vs Zepp Health Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAAPL (2025)ZEPP (2025)
Revenue/Sales i416.16BN/A
Cost of Goods Sold i220.96BN/A
COGS % of Revenue i53.1%-
Gross Profit i195.20BN/A
Gross Margin i46.9%-
Research & Development i34.55BN/A
Operating Income (EBIT) i133.05BN/A
Operating Margin i32.0%-
EBITDA i144.75BN/A
EBITDA Margin i34.8%-
Pre-Tax Income i132.73BN/A
Pre-Tax Income % of Revenue i31.9%-
Income Tax i20.72BN/A
Income Tax % of Revenue i5.0%-
Net Income (Profit) i112.01BN/A
Profit Margin i26.9%-

Balance Sheet & Liquidity Metrics

MetricAAPL (2025)ZEPP (2025)
Cash & Equivalents i35.93B91.07M
Total Current Assets i147.96B251.56M
Total Current Assets % of Revenue i35.6%-
Total Current Liabilities i165.63B195.37M
Total Current Liabilities % of Revenue i39.8%-
Long-Term Debt i78.33B77.25M
Long-Term Debt % of Revenue i18.8%-
Total Shareholders Equity i73.73B252.73M
Retained Earnings i-14.26B28.62M
Retained Earnings % of Revenue i-3.4%-
Property, Plant & Equipment i03.46M

Cash Flow Statement Comparison

MetricAAPL (2025)ZEPP (2025)
Operating Cash Flow i111.48B-25.97M
Operating Cash Flow % of Revenue i26.8%-
Capital Expenditures i-12.72B-707,000
Free Cash Flow i98.77B-25.88M
FCF Margin i23.7%-
Debt Repayment i-10.93B-12.60M
Common Stock Repurchase i-90.71B-2.28M

Short Interest & Institutional Ownership Analysis

MetricAAPLZEPP
Shares Short i134.42M463,069
Short Ratio i3.244.16
Short % of Float i0.92%7.68%
Shares Outstanding i14.70B7.04M
Float Shares i14.66B96.40M
% Held by Insiders i1.64%7.64%
% Held by Institutions i65.23%63.11%
% Held by Public i33.13%29.25%

Dividend Analysis & Yield Comparison: Apple Inc. vs Zepp Health Corporation

MetricAAPLZEPP
Last 12-Month Dividend i$1.29$0.00
Last 12-Month Dividend Yield i0.48%N/A
3-Year Avg Annual Dividend i$1.08$0.00
3-Year Avg Dividend Yield i0.12%N/A
3-Year Total Dividends i$3.23$0.00
Ex-Dividend DateFeb 09, 2026N/A